Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2008
12/24/2008CN101328156A Hydroxamic acids derivates containing 1,3 biheterocycle five-membered rings and use thereof
12/24/2008CN101328155A Oxazolidine derivates, preparation and application thereof
12/24/2008CN100445271C Amide derivative
12/24/2008CA2691309A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
12/24/2008CA2689525A1 Cetp inhibitors derived from benzoxazole arylamides
12/24/2008CA2689523A1 Cetp inhibitors derived from benzoxazole arylamides
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008152306A2 Novel peptidase substrates
12/18/2008WO2008152305A2 Novel nitroreductase enzymatic substrates
12/18/2008WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
12/18/2008WO2008079339A3 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
12/18/2008US20080312436 Colorless Water-Soluble Organic Luminophores and Intermediates Thereof
12/18/2008US20080312435 Imine Compound
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312291 Heterocyclic Gaba-b Modulators
12/18/2008US20080312207 Compounds
12/18/2008US20080311113 Method for treating adamts-5-associated disease
12/18/2008US20080308770 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
12/17/2008EP2001472A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/17/2008EP1919883B1 N-oxides as prodrugs of piperazine&piperidine derivatives
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008CN101326169A Glucocorticoid receptor modulators as antiinflammatory agents
12/17/2008CN101326155A Propionamide compounds as antiinflammatory agents
12/17/2008CN101323602A 2-oxazoline derivates and method for preparing the same
12/17/2008CN101323589A Preparation of novel compound and montelukast sodium
12/17/2008CN100443480C Tricyclic compound and its preparation and use
12/17/2008CN100443477C Substituted benzoxazoles and analogues as estrogenic agents
12/17/2008CN100443475C Compound of 2-substituted alkylacrylate and application thereof
12/17/2008CN100443467C Substituted aromatic amide derivative intemediate thereof, agrohorticultral insecticide containing thereof and method for use thereof
12/16/2008US7465804 3-[p-(substituted benzyloxy)- or p-(substituted -5-thiazolylmethoxy)phenyl]propionic acid derivatives in which the propionic acid is 3-substituted with a carbamoyl-, imidazolyl-, triazolyl-, tetrazolyl-, or oxazolyl group; activating G-protein coupled receptor 40; treatment of type II diabetes
12/16/2008US7465720 Proteasome inhibiting β-lactam compounds
12/11/2008WO2008150406A1 A process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
12/11/2008WO2008024892A3 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/11/2008US20080306279 Synthesis Intermediates Useful For Preparing Zolmitriptan
12/11/2008US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof
12/11/2008US20080305051 Menthane Carboxamide Derivatives Having Cooling Properties
12/11/2008DE112007000299T5 Verfahren zur Herstellung von aromatischer Verbindung Process for the preparation of aromatic compound
12/11/2008DE102007026341A1 Benzoxazolonderivate Benzoxazolonderivate
12/11/2008CA2688432A1 A process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008CN101321741A Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
12/10/2008CN101318941A Method for preparing 6-chlorine-2-(para hydroxyl) phenoxy benzoxazole
12/10/2008CN100441574C Tricyclic compounds, their production and use
12/09/2008US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
12/09/2008US7462633 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/04/2008US20080300287 Peptidic Compounds
12/04/2008US20080300286 Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma
12/04/2008US20080299041 Heterocyclic indene derivatives and their radioisotope labeled compounds for imaging beta-amyloid deposition
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008CN101316824A Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests
12/03/2008CN100439347C 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
12/03/2008CN100439346C Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
12/03/2008CN100439345C (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
11/2008
11/27/2008WO2008143254A1 Pharmaceutical containing pparδ agonist
11/27/2008WO2008141976A1 Diacylglycerol acyltransferase inhibitors
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008US20080293950 Production Process of Compound Having Anti-Hcv Action and Intermediate Thereof
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293569 Indanyl- and Tetrahydronaphthyl-Amino-Azoline Compounds for Combating Animal Pests
11/27/2008US20080290329 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
11/27/2008CA2687957A1 Pharmaceutical containing ppar.delta. agonist
11/27/2008CA2686951A1 Diacylglycerol acyltransferase inhibitors
11/26/2008EP1994017A2 Novel heterocyclic nf-kb inhibitors
11/26/2008EP1994016A2 5-phenyl-3-benzyl-oxazolidin-2-one derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders
11/26/2008EP1802566B1 Hexafluoroisopropanol substituted ether derivatives
11/26/2008EP1480642B1 Peroxisome proliferator activated receptor modulators
11/26/2008EP0945448B1 5-alkoxy-2(3h)-oxazolone compounds and process for the preparation thereof
11/26/2008CN100436430C Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008US7456204 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139467A2 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
11/20/2008WO2008139161A1 Oxazole tyrosine kinase inhibitors
11/20/2008WO2008138591A2 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
11/20/2008WO2008119685A3 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
11/20/2008US20080286486 Carbonate Containing Energy-Curable Compositions
11/19/2008CN101309912A Oxazole compound and pharmaceutical composition
11/19/2008CN101309911A Hiv-1 protease inhibitors, and methods of making and using them
11/19/2008CN101307036A Method for preparing 2,6-dichloro benzoxazole
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing
11/18/2008US7453002 Five-membered heterocycles useful as serine protease inhibitors
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008135181A2 Insecticidal substituted 2-aminoindanes
11/13/2008US20080280963 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/13/2008US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects
11/12/2008EP1990365A1 Resin composition
11/12/2008EP1718623B1 Compounds as inhibitors of cell proliferation and viral infections
11/12/2008CN101304984A Oxazole and thiazole ppar modulator
11/12/2008CN101304983A Compounds and compositions as PPAR modulators
11/12/2008CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 210